Reaping rewards. Risking reputation.
Pharmaceuticals in the GenAI era
GenAI is transforming pharmaceutical workflows at unprecedented speed, powering everything from research and regulatory submissions to marketing and investor communications. But as content production accelerates, governance is falling dangerously behind, exposing organisations to risks like misinformation, plagiarism, and IP breaches.
This report explores the growing gap between AI-driven output and human-led oversight and what it means for trust, compliance, and reputation. Drawing on insights from senior pharma leaders, it reveals the hidden assumptions putting organisations at risk and outlines how to build smarter, scalable governance into modern workflows
What you’ll learn:
- How GenAI is reshaping pharmaceutical content creation across every function
- The biggest misconceptions putting organisations at risk
- Why traditional review processes can’t keep up with AI-generated content
- The real-world impact of AI errors on trust, compliance, and culture
- How to embed fast, scalable governance without slowing innovation